VxP Pharma and VxP Biologics Revenue and Competitors

VxP Pharma and VxP Biologics provide the development and manufacture of both small molecule pharmaceutical products, as well as complete development and manufacture of biologics, including mammalian and microbial products, as well as live virus vaccines. We also offer preclinical/toxicology in most animal models including NHP, as well as supporting analytical. Many of our facilities are part of the US Bio-Defense Grid, providing global countermeasures and public health products, so you can be assured that VxP facilities are fully capable, and fully vetted by the US-FDA. Although most operations are located in the United States, some facilities are located in Europe, India and East Asia. The majority of these sites have been US-FDA audited, and all have a long track record of successful collaborations with global pharma clients, virtual companies, and everything in between. Whether it be a small molecule program, or a biologic, VxP can provide the guidance, the services, and the regulatory support necessary to accelerate your development program and get you into the clinic, or to market in an efficient and cost effective manner. VxP Pharma, Inc. VxP Biologics, Inc. www.VxPPharma.com www.VxPBiologics.com